These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9506206)

  • 1. Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double-blinded, placebo-controlled trial.
    Stephenson MD; Dreher K; Houlihan E; Wu V
    Am J Reprod Immunol; 1998 Feb; 39(2):82-8. PubMed ID: 9506206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled study.
    Jablonowska B; Selbing A; Palfi M; Ernerudh J; Kjellberg S; Lindton B
    Hum Reprod; 1999 Mar; 14(3):838-41. PubMed ID: 10221723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial.
    Stephenson MD; Kutteh WH; Purkiss S; Librach C; Schultz P; Houlihan E; Liao C
    Hum Reprod; 2010 Sep; 25(9):2203-9. PubMed ID: 20634190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin in the prevention of recurrent spontaneous abortion: the European experience.
    Christiansen OB
    Am J Reprod Immunol; 1998 Feb; 39(2):77-81. PubMed ID: 9506205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy with intravenous immunoglobulin for treatment of recurrent pregnancy loss: American experience.
    Coulam CB
    Am J Reprod Immunol; 1994 Dec; 32(4):286-9. PubMed ID: 7718095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin for treatment of recurrent pregnancy loss.
    Coulam CB; Krysa L; Stern JJ; Bustillo M
    Am J Reprod Immunol; 1995 Dec; 34(6):333-7. PubMed ID: 8607936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v. immunoglobulin.
    Christiansen OB; Mathiesen O; Husth M; Rasmussen KL; Ingerslev HJ; Lauritsen JG; Grunnet N
    Hum Reprod; 1995 Oct; 10(10):2690-5. PubMed ID: 8567794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin therapy for recurrent spontaneous abortion: a meta-analysis.
    Daya S; Gunby J; Clark DA
    Am J Reprod Immunol; 1998 Feb; 39(2):69-76. PubMed ID: 9506204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy with intravenous immunoglobulin for prevention of recurrent pregnancy loss: European experience.
    Mueller-Eckhardt G
    Am J Reprod Immunol; 1994 Dec; 32(4):281-5. PubMed ID: 7718094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin in the prevention of recurrent miscarriage. The German RSA/IVIG Group.
    Br J Obstet Gynaecol; 1994 Dec; 101(12):1072-7. PubMed ID: 7826961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage.
    Christiansen OB; Pedersen B; Rosgaard A; Husth M
    Hum Reprod; 2002 Mar; 17(3):809-16. PubMed ID: 11870141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking antibodies in blood from patients with recurrent spontaneous abortion in relation to pregnancy outcome and intravenous immunoglobulin treatment.
    Jablonowska B; Palfi M; Ernerudh J; Kjellberg S; Selbing A
    Am J Reprod Immunol; 2001 Apr; 45(4):226-31. PubMed ID: 11327549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin treatment for secondary recurrent miscarriage: a randomised, double-blind, placebo-controlled trial.
    Christiansen OB; Larsen EC; Egerup P; Lunoee L; Egestad L; Nielsen HS
    BJOG; 2015 Mar; 122(4):500-8. PubMed ID: 25412569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immune globulin in recurrent abortion.
    Heine O; Mueller-Eckhardt G
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):39-42. PubMed ID: 8033433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intravenous immunoglobulin passive immunotherapy on unexplained recurrent spontaneous abortion: a meta-analysis.
    Wang SW; Zhong SY; Lou LJ; Hu ZF; Sun HY; Zhu HY
    Reprod Biomed Online; 2016 Dec; 33(6):720-736. PubMed ID: 27720163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonographic findings of pregnancy losses after treatment for recurrent pregnancy loss: intravenous immunoglobulin versus placebo.
    Coulam CB; Stern JJ; Bustillo M
    Fertil Steril; 1994 Feb; 61(2):248-51. PubMed ID: 8299777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin for recurrent unexplained pregnancy loss: a case report.
    Barnsfather K; Pietrantoni M
    J Reprod Med; 2007 Aug; 52(8):737-40. PubMed ID: 17879838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin.
    Stricker RB; Steinleitner A; Bookoff CN; Weckstein LN; Winger EE
    Fertil Steril; 2000 Mar; 73(3):536-40. PubMed ID: 10689009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.
    Banjar S; Kadour E; Khoudja R; Ton-Leclerc S; Beauchamp C; Beltempo M; Dahan MH; Gold P; Jacques Kadoch I; Jamal W; Laskin C; Mahutte N; Reinblatt SL; Sylvestre C; Buckett W; Genest G
    Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial.
    Nørgaard-Pedersen C; Nielsen K; Steffensen R; Eriksen L; Jørgensen MM; Kesmodel US; Christiansen OB
    BMJ Open; 2022 Sep; 12(9):e064780. PubMed ID: 36137638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.